GDUFA Research Outcomes
Transdermal Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the transdermal route, including transdermal delivery systems.
-
Generic Drugs and Their Role in Bringing Next Generation Products: An FDA Perspective
Luke, Markham
-
Combination Drug-Device Products as Complex Generic Drugs- Summary of Presentations and Horizon Scanning for Future Scientific Research
Luke, Markham
-
Bioequivalence of Tansdermal Delivery Systems-Scientific Merits of the U.S. Approach
Luke, Markham
-
Drug Compounding and the Dermatologist
Luke, Markham
-
Closing Remarks
Lionberger, Robert
-
Topical Bioequivalence Update
Lionberger, Robert
-
Topical Bioequivalence Update
Lionberger, Robert
-
Advantages and Challenges in Implementing New Analytical Methods that Arise from Regulatry Science Initiatives
Kozak, Darby
-
Advantages and Challenges in Implementing New Analytical Methods that Arise from Regulatry Science Initiatives
Kozak, Darby
-
An FDA Perspective on the Comparative Analyses of Critical Material, Quality, and Design Attributes for Topical, Transdermal, Rectal, and Vaginal Drug-Device Combination Products
Kelchen, Megan